333 related articles for article (PubMed ID: 22825057)
1. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin.
Yang N; Morrison CD; Liu P; Miecznikowski J; Bshara W; Han S; Zhu Q; Omilian AR; Li X; Zhang J
Cell Cycle; 2012 Aug; 11(15):2922-30. PubMed ID: 22825057
[TBL] [Abstract][Full Text] [Related]
2. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.
Zhang J; Ji JY; Yu M; Overholtzer M; Smolen GA; Wang R; Brugge JS; Dyson NJ; Haber DA
Nat Cell Biol; 2009 Dec; 11(12):1444-50. PubMed ID: 19935651
[TBL] [Abstract][Full Text] [Related]
3. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
Bade LK; Goldberg JE; Dehut HA; Hall MK; Schwertfeger KL
J Cell Sci; 2011 Sep; 124(Pt 18):3106-17. PubMed ID: 21868365
[TBL] [Abstract][Full Text] [Related]
4. Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system.
Fukuda S; Nishida-Fukuda H; Nanba D; Nakashiro K; Nakayama H; Kubota H; Higashiyama S
Sci Rep; 2016 Feb; 6():20209. PubMed ID: 26831618
[TBL] [Abstract][Full Text] [Related]
5. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.
Sternlicht MD; Sunnarborg SW
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):181-94. PubMed ID: 18470483
[TBL] [Abstract][Full Text] [Related]
6. Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.
Nickerson NK; Mill CP; Wu HJ; Riese DJ; Foley J
Oncol Res; 2013; 20(7):303-17. PubMed ID: 23879171
[TBL] [Abstract][Full Text] [Related]
7. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer.
Baillo A; Giroux C; Ethier SP
J Cell Physiol; 2011 Oct; 226(10):2691-701. PubMed ID: 21302279
[TBL] [Abstract][Full Text] [Related]
8. Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop.
Stiehl DP; Bordoli MR; Abreu-Rodríguez I; Wollenick K; Schraml P; Gradin K; Poellinger L; Kristiansen G; Wenger RH
Oncogene; 2012 May; 31(18):2283-97. PubMed ID: 21927022
[TBL] [Abstract][Full Text] [Related]
9. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers.
Kariagina A; Xie J; Leipprandt JR; Haslam SZ
Horm Cancer; 2010 Oct; 1(5):229-44. PubMed ID: 21258428
[TBL] [Abstract][Full Text] [Related]
10. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.
Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L
Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 determines estrogen signaling in the mammary gland in vivo.
Casimiro MC; Wang C; Li Z; Di Sante G; Willmart NE; Addya S; Chen L; Liu Y; Lisanti MP; Pestell RG
Mol Endocrinol; 2013 Sep; 27(9):1415-28. PubMed ID: 23864650
[TBL] [Abstract][Full Text] [Related]
12. Metalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin.
Stoll SW; Johnson JL; Bhasin A; Johnston A; Gudjonsson JE; Rittié L; Elder JT
J Invest Dermatol; 2010 Jan; 130(1):295-304. PubMed ID: 19609315
[TBL] [Abstract][Full Text] [Related]
13. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.
Willmarth NE; Ethier SP
J Biol Chem; 2006 Dec; 281(49):37728-37. PubMed ID: 17035230
[TBL] [Abstract][Full Text] [Related]
14. Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells.
Hirota N; Risse PA; Novali M; McGovern T; Al-Alwan L; McCuaig S; Proud D; Hayden P; Hamid Q; Martin JG
FASEB J; 2012 Apr; 26(4):1704-16. PubMed ID: 22247333
[TBL] [Abstract][Full Text] [Related]
15. Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth.
Stoll SW; Johnson JL; Li Y; Rittié L; Elder JT
J Invest Dermatol; 2010 Aug; 130(8):2031-40. PubMed ID: 20428186
[TBL] [Abstract][Full Text] [Related]
16. Validation of HB-EGF and amphiregulin as targets for human cancer therapy.
Yotsumoto F; Yagi H; Suzuki SO; Oki E; Tsujioka H; Hachisuga T; Sonoda K; Kawarabayashi T; Mekada E; Miyamoto S
Biochem Biophys Res Commun; 2008 Jan; 365(3):555-61. PubMed ID: 18023415
[TBL] [Abstract][Full Text] [Related]
17. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad.
Nickerson NK; Mohammad KS; Gilmore JL; Crismore E; Bruzzaniti A; Guise TA; Foley J
PLoS One; 2012; 7(1):e30255. PubMed ID: 22276166
[TBL] [Abstract][Full Text] [Related]
18. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
19. The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop.
Wang X; Masri S; Phung S; Chen S
Cancer Res; 2008 Apr; 68(7):2259-65. PubMed ID: 18381432
[TBL] [Abstract][Full Text] [Related]
20. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
